oAlert.pl

Recalled Medicines & supplements – Current GIS Alerts 2026

Found 713 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.

Common hazards in this category

All recalled products

Triderm – recalled product

Triderm

HIGH 29.10.2020

The occurrence of incorrect information on the outer packaging regarding the repackaging site and the name of the parallel importer was classified as a quality defect of the medicinal product. Potential effects: incorrect use of the drug, inability to identify the responsible entity, possible therapy complications.

Lisinoratio 5 – recalled product

Lisinoratio 5

HIGH 16.10.2020

Suspected contamination of the batch of Lisinoratio 5, 5 mg, tablets with ibuprofen as an undesired substance, which is a potential quality defect that may endanger patients’ health. Potential effects: adverse reactions, drug interactions, complications involving kidneys and cardiovascular system.

Oxydolor – recalled product

Oxydolor

HIGH 28.08.2020

Stability studies of the product batches showed an out-of-specification result for active substance content, which may lead to incorrect dosing of the medicine. Potential effects: lack of treatment efficacy or overdose, complications, risk to health.

Krople uspokajające spokojne – recalled product

Krople uspokajające spokojne

HIGH 12.08.2020

the tested sample of the medicinal product Krople uspokajające spokojne did not meet the requirements specified in the product documentation for total aerobic microbial count (TAMC). This quality defect may pose a potential risk to the health or life of patients. Potential effects: infections, complications, health risk.

Gliceryna – recalled product

Gliceryna

MEDIUM 06.08.2020

It was found that test results for batches of the pharmaceutical raw material GLICERYNA 85% are out of specification for the parameters: aldehydes and sugars, which means failure to meet established quality requirements for a medicinal product. Potential effects: reduced quality of preparations, possible irritation or other adverse reactions.

Allergo-Comod – recalled product

Allergo-Comod

MEDIUM 13.07.2020

Irregularities in the assembly of the dispenser pump housing were found, causing incorrect drop size or inability to dispense drops from the bottle. Potential effects: lack of treatment efficacy, worsening of allergy symptoms, possible discomfort or eye irritation.

Timo-COMOD 0,5 % – recalled product

Timo-COMOD 0,5 %

MEDIUM 13.07.2020

Irregularities in the assembly of the dispenser pump housing were found, resulting in improper drop size or inability to dispense drops from the dispenser. Potential effects: lack of treatment efficacy, incorrect dosing, possible worsening of the eye condition.

Minirin – recalled product

Minirin

CRITICAL 10.07.2020

In some packs, an incorrect liquid volume and results not complying with the specification for desmopressin and benzalkonium chloride content were found, meaning the dose and safety of the product cannot be assured. Potential effects: lack of treatment efficacy or overdose, adverse reactions, complications.

Octostim – recalled product

Octostim

HIGH 10.07.2020

Incorrect volume was detected in some packs and out-of-specification results for the content of the active substance desmopressin and the excipient benzalkonium chloride. Potential effects: lack of treatment efficacy or adverse effects due to incorrect dosing.

Dicortineff – recalled product

Dicortineff

MEDIUM 25.06.2020

Occurrence of a quality defect in the medicinal product in the fludrocortisone acetate parameter, confirmed in stability testing and an archival sample. Potential effects: possible lack of treatment efficacy or unpredictable adverse reactions.

Ventolin – recalled product

Ventolin

HIGH 23.06.2020

The quality defect consists in marking the batch with a unique identifier indicating in the system that the batch is withdrawn, which prevents dispensing the product to patients and may lead to lack of availability of the medicine. Potential effects: lack of effective treatment, deterioration of health.

Megalia – recalled product

Megalia

HIGH 18.06.2020

Out-of-specification results were found regarding microbiological purity in batches of the medicinal product Megalia. Potential effects: infection, complications, risk to patients' health.

Monural – recalled product

Monural

CRITICAL 17.06.2020

Use of the product, for which the benefit-risk balance was judged negative, poses a threat to public health and may directly endanger patients’ health or life. Potential effects: serious adverse reactions, lack of treatment efficacy, complications threatening health or life.

Monural – recalled product

Monural

HIGH 17.06.2020

Use of this product, for which the benefit–risk ratio has been considered negative, poses a threat to public health. Potential effects: serious adverse reactions, health risk, possible complications.

Uromaste – recalled product

Uromaste

HIGH 17.06.2020

Use of the product, for which the benefit–risk balance was assessed as negative, poses a threat to public health; there is a significant probability of real harm to patients’ health or life. Potential effects: treatment complications, lack of efficacy, threat to health or life.

Uromaste – recalled product

Uromaste

HIGH 17.06.2020

It was found that use of the product, for which the benefit–risk balance was judged negative, poses a threat to public health. Potential effects: serious adverse reactions or lack of effectiveness in infection treatment.

Furosemidum Polfarmex – recalled product

Furosemidum Polfarmex

HIGH 15.06.2020

The quality defect involves a mix-up of Furosemidum Polfarmex and Nasen packs, creating a risk that patients take the wrong medicine and consequently face a threat to their life or health. Potential effects: lack of efficacy, increased adverse effects, serious complications, life-threatening situations.

Nasen – recalled product

Nasen

HIGH 15.06.2020

A quality defect consisting in placing in the outer packaging of one medicinal product the blisters of another medicinal product, creating a risk that the patient will take the wrong medicine. Potential effects: inappropriate treatment, lack of therapeutic efficacy, serious adverse reactions.

Espumisan – recalled product

Espumisan

HIGH 10.06.2020

Information leaflets for the medicinal product Zentel tablets were detected in some packs instead of the correct ESPUMISAN leaflet. Potential effects: improper use of the medicine, incorrect dosing, lack of efficacy or adverse reactions.

Groprinosin Max – recalled product

Groprinosin Max

HIGH 15.05.2020

Out-of-specification results were found in antimicrobial preservation efficacy tests for Groprinosin MAX, meaning lack of adequate preservation and a risk of infection after use. Potential effects: infections, complications, health risk for patients.

What to do if you bought a recalled product?

If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.